Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration

This publication has 20 references indexed in Scilit:

• Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection
  Psychopharmacology, 1992
• Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission
  Neuropharmacology, 1991
• Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: An autoradiographic study
  Neuropharmacology, 1991
• Serotonin-Specific Drugs for Anxiety and Depressive Disorders
  Annual Review of Medicine, 1990
• The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
• Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat
  Neuropharmacology, 1988
• Potential anxiolytic properties of 8-hydroxy-2-(Di-N-propylamino)tetralin, a selective serotonin1A receptor agonist
  Psychopharmacology, 1988
• Modification of 5‐HT neuron properties by sustained administration of the 5‐HT_1A agonist gepirone: Electrophysiological studies in the rat brain
  Synapse, 1987
• [³H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain
  Journal of Neurochemistry, 1985
• 5-HT and anxiety
  Neuropharmacology, 1984